Follow
Kancera AB
Nasdaq First North GM (Sweden)
Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
KAN
SE0003622265
Nasdaq First North GM
Sweden (SE)
Details of share in Kancera AB with ticker KAN
Status
Active
Order book id
Amount of instruments
436 404 617
Par value
Market cap
Currency
SEK
Segment
First North Premier
First trading date
25 Feb 2011
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
7.00 SEK
67.5M SEK
30 Nov - 14 Dec 2010
IPO in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.69 SEK
12.9M SEK
13 Nov - 07 Dec 2012
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
16.1M SEK
25 Nov - 11 Dec 2013
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Exercise
0.75 SEK
01 May - 31 May 2014
Option exercise terms for KAN TO 1
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
246.37M SEK
06 May - 27 May 2015
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
260M SEK
10 May - 25 May 2016
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
01 Oct 2016 - 30 Jun 2017
Option exercise terms for KAN TO 2
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.80 SEK
236.7M SEK
12 May - 30 May 2017
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.20 SEK
178M SEK
04 May - 22 May 2018
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Exercise
1.95 SEK
22 May - 22 Nov 2019
Option exercise terms for KAN TO 3
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.39 SEK
81.9M SEK
17 Mar - 31 Mar 2020
Share issue in Kancera AB
Type
Ticker
ISIN
Market
OPTION
KAN TO4
SE0013914777
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO4
Status
Active
Order book id
196717
Amount of instruments
179 269 322
Market cap
Currency
SEK
Trading period
13 May 2020 - 26 Mar 2021
Terms
Two (2) warrants of series TO 4 entitles to subscribe for one (1) new share in the Company.
Update (16.06.2020): Kancera is awarded approximately SEK 22 million through the exercise of warrants of series TO4, which is expected to provide funding for clinical cardiac study with KAND567.
Update (15.09.2020): The redemption period for Kancera's warrant expires in September 2020.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.47 SEK
04 May - 30 Sep 2020
01 Mar - 31 Mar 2021
Option exercise terms for KAN TO4
Type
Ticker
ISIN
Market
OPTION
KAN TO5
SE0013914785
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO5
Status
Active
Order book id
196718
Amount of instruments
157 369 119
Market cap
Currency
SEK
Trading period
13 May 2020 - 26 Nov 2021
Terms
Three (3) warrants of series TO5 entitles to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
01 Jun - 30 Nov 2021
Option exercise terms for KAN TO5
Type
Ticker
ISIN
Market
SHARE
KAN
SE0003622265
Nasdaq First North GM
Sweden (SE)
Details of share in Kancera AB with ticker KAN
Status
Active
Order book id
Amount of instruments
436 404 617
Par value
Market cap
Currency
SEK
Segment
First North Premier
First trading date
25 Feb 2011
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
7.00 SEK
67.5M SEK
30 Nov - 14 Dec 2010
IPO in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.69 SEK
12.9M SEK
13 Nov - 07 Dec 2012
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
16.1M SEK
25 Nov - 11 Dec 2013
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
246.37M SEK
06 May - 27 May 2015
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.50 SEK
260M SEK
10 May - 25 May 2016
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.80 SEK
236.7M SEK
12 May - 30 May 2017
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.20 SEK
178M SEK
04 May - 22 May 2018
Share issue in Kancera AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.39 SEK
81.9M SEK
17 Mar - 31 Mar 2020
Share issue in Kancera AB
Type
Ticker
ISIN
Market
OPTION
KAN TO 1
SE0005560141
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO 1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
Trading period
29 Jan 2014 - 27 May 2014
Terms
Two (2) warrants of series TO 1 entitles to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.75 SEK
01 May - 31 May 2014
Option exercise terms for KAN TO 1
Type
Ticker
ISIN
Market
OPTION
KAN TO 2
SE0008321673
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO 2
Status
Archived
Order book id
124272
Amount of instruments
Market cap
Currency
SEK
Trading period
11 Jul 2016 - 28 Apr 2018
Terms
The company issues 20 785 072 Units. One (1) Unit consists of one (1) share and one (1) warrant of series TO 2. Two (2) warrants entitles to subscribe for one (1) new share in the Company for SEK 5 during the subscription period from October 1, 2016 until June 30, 2017 and for SEK 6 during the subscription period up to and including April 30, 2018.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
01 Oct 2016 - 30 Jun 2017
Option exercise terms for KAN TO 2
Type
Ticker
ISIN
Market
OPTION
KAN TO 3
SE0011167386
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO 3
Status
Archived
Order book id
157649
Amount of instruments
Market cap
Currency
SEK
Segment
First North Premier
Trading period
09 Jul 2018 - 20 Nov 2019
Terms
Two (2) warrants entitles to subscribe for one (1) new share in the Company for SEK 1.95 during the subscription period from the May 22, 2019 until November 22, 2019.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.95 SEK
22 May - 22 Nov 2019
Option exercise terms for KAN TO 3
Type
Ticker
ISIN
Market
OPTION
KAN TO4
SE0013914777
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO4
Status
Active
Order book id
196717
Amount of instruments
179 269 322
Market cap
Currency
SEK
Trading period
13 May 2020 - 26 Mar 2021
Terms
Two (2) warrants of series TO 4 entitles to subscribe for one (1) new share in the Company.
Update (16.06.2020): Kancera is awarded approximately SEK 22 million through the exercise of warrants of series TO4, which is expected to provide funding for clinical cardiac study with KAND567.
Update (15.09.2020): The redemption period for Kancera's warrant expires in September 2020.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.47 SEK
04 May - 30 Sep 2020
01 Mar - 31 Mar 2021
Option exercise terms for KAN TO4
Type
Ticker
ISIN
Market
OPTION
KAN TO5
SE0013914785
Nasdaq First North GM
Sweden (SE)
Details of option in Kancera AB with ticker KAN TO5
Status
Active
Order book id
196718
Amount of instruments
157 369 119
Market cap
Currency
SEK
Trading period
13 May 2020 - 26 Nov 2021
Terms
Three (3) warrants of series TO5 entitles to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
01 Jun - 30 Nov 2021
Option exercise terms for KAN TO5
People
Number of Employees
9 people
Thomas Olin
CEO
Erik Nerpin
Chairman of the board
Thomas Olin
Board member
Erik Nerpin
Board member
Håkan Mellstedt
Board member
Charlotte Edenius
Board member
Carl-Henrik Heldin
Board member
Anders Gabrielsen
Board member
Company Details
Sector
HEALTH CARE
Website

Address
C/O Karolinska Institutet Science P
Zip code
171 48
City/district
Solna
Country
Sweden (SE)
Registration number
556806-8851
LEI code
5493002P3RCOFW6HI207
First trade date
25 Feb 2011
Registration date
28 Apr 2010
Short name
Kancera

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date